Cargando…

The Biocomplex Assembled from Antigen Peptide and Toll-like Receptor Agonist Improved the Immunity against Pancreatic Adenocarcinoma In Vivo

PURPOSE: One of the biggest challenges in cancer immunotherapy is generating robust cancer-specific immunity. This work describes using a biocomplex assembled from a toll-like receptor agonist CpG oligodeoxynucleotide 1826 (CpG) and a pancreatic cancer antigen peptide mesothelin for tuning pancreati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Wenming, Yu, Hongbin, Xue, Tao, Wu, Chunyong, Ren, Fan, Cui, Ge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436581/ https://www.ncbi.nlm.nih.gov/pubmed/36059807 http://dx.doi.org/10.1155/2022/2965496

Ejemplares similares

Screening of novel peptides that specifically interact with vitamin D bound biocomplex proteins
por: Kim, Taehwan, et al.
Publicado: (2023)

Investigating biocomplexity through the agent-based paradigm
por: Kaul, Himanshu, et al.
Publicado: (2015)

Biocomplexity in Populations of European Anchovy in the Adriatic Sea
por: Ruggeri, Paolo, et al.
Publicado: (2016)

Emerging and Reemerging Infectious Diseases: Biocomplexity as an Interdisciplinary Paradigm
por: Wilcox, Bruce A., et al.
Publicado: (2005)

Unravelling biocomplexity of electroactive biofilms for producing hydrogen from biomass
por: Lewis, Alex J., et al.
Publicado: (2017)

A migration-associated supergene reveals loss of biocomplexity in Atlantic cod
por: Kess, Tony, et al.
Publicado: (2019)

Earlier Migration Timing, Decreasing Phenotypic Variation, and Biocomplexity in Multiple Salmonid Species
por: Kovach, Ryan P., et al.
Publicado: (2013)

A biocomplex to repair experimental critical size defects associated with photobiomodulation therapy
por: Buchaim, Daniela Vieira, et al.
Publicado: (2022)

Human Dental Pulp Stem Cells Hook into Biocoral Scaffold Forming an Engineered Biocomplex
por: Mangano, Carlo, et al.
Publicado: (2011)

Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Focus on Mitochondrial DNA and Alzheimer’s Disease
por: Zaia, Annamaria, et al.
Publicado: (2017)

Adaptive genetic variation underlies biocomplexity of Atlantic Cod in the Gulf of Maine and on Georges Bank
por: Clucas, G. V., et al.
Publicado: (2019)

Biocomplexity and Fractality in the Search of Biomarkers of Aging and Pathology: Mitochondrial DNA Profiling of Parkinson’s Disease
por: Zaia, Annamaria, et al.
Publicado: (2020)

Small-scale biocomplexity in coastal Atlantic cod supporting a Darwinian perspective on fisheries management
por: Olsen, Esben Moland, et al.
Publicado: (2008)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Spatiotemporal SNP analysis reveals pronounced biocomplexity at the northern range margin of Atlantic cod Gadus morhua
por: Therkildsen, Nina Overgaard, et al.
Publicado: (2013)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens
por: Lafitte, Marie, et al.
Publicado: (2012)

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
por: Shanmugam, Arulkumaran, et al.
Publicado: (2012)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll like receptor agonists
por: Triozzi, Pierre L., et al.
Publicado: (2011)

In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori
por: Haghighi, Mohamad Ali, et al.
Publicado: (2013)

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
por: Rolfo, Christian, et al.
Publicado: (2023)

Effects of a Biocomplex Formed by Two Scaffold Biomaterials, Hydroxyapatite/Tricalcium Phosphate Ceramic and Fibrin Biopolymer, with Photobiomodulation, on Bone Repair
por: Reis, Carlos Henrique Bertoni, et al.
Publicado: (2022)

The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells
por: Guo, Xueheng, et al.
Publicado: (2017)

Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses
por: Wang, Nannan, et al.
Publicado: (2022)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists for cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
por: Chi, Huju, et al.
Publicado: (2017)

A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population
por: Wu, Chiao-Chieh, et al.
Publicado: (2016)

Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses
por: Ebrahimian, Mahboubeh, et al.
Publicado: (2017)

Multivalent, Stabilized Mannose‐6‐Phosphates for the Targeted Delivery of Toll‐Like Receptor Ligands and Peptide Antigens
por: Reintjens, Niels R. M., et al.
Publicado: (2020)

Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
por: Chan, Michael, et al.
Publicado: (2009)

Toll-like receptor 2 agonists inhibit human fibrocyte differentiation
por: Maharjan, Anu S, et al.
Publicado: (2010)

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
por: Martinsen, Janne Tegder, et al.
Publicado: (2020)

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
por: Macedo, Amanda B., et al.
Publicado: (2019)

Bibliometric analysis of toll-like receptor agonists associated with cancer therapy
por: Li, Wei, et al.
Publicado: (2022)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
por: Liu, Zhi-Mei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_htelrj8m2vqqu8d1ak3ptiospa